- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 16/02 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux provenant d'œufs
Détention brevets de la classe C07K 16/02
Brevets de cette classe: 131
Historique des publications depuis 10 ans
|
6
|
9
|
8
|
10
|
11
|
19
|
7
|
5
|
7
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Wisconsin Alumni Research Foundation | 3890 |
7 |
| Ostrich Pharma KK | 16 |
7 |
| Adbiotech Co., Ltd. | 10 |
5 |
| Camas Incorporated | 27 |
5 |
| Arkion Life Sciences, LLC | 47 |
4 |
| The United States of America, as represented by the Secretary of Agriculture | 1118 |
4 |
| Universidade de Aveiro | 164 |
3 |
| Norifish AS | 3 |
3 |
| Agrivida, Inc. | 64 |
2 |
| Alexion Pharmaceuticals, Inc. | 640 |
2 |
| City of Hope | 1004 |
2 |
| Crystal Bioscience Inc. | 84 |
2 |
| Investigación Aplicada S.A. de C.V. | 6 |
2 |
| Luberski, Inc., DBA Hidden Villa Ranch | 39 |
2 |
| Mat Malta Advanced Technologies Limited | 11 |
2 |
| Taipei Medical University | 207 |
2 |
| Ignova GmbH | 5 |
2 |
| Instituto Nacional de Salud | 2 |
2 |
| Romvac Company SA | 4 |
2 |
| Shenzhen Sino-swed Tongkang Bio-Tech Limited | 3 |
2 |
| Autres propriétaires | 69 |